Compare HRMY & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRMY | CABO |
|---|---|---|
| Founded | 2017 | 1980 |
| Country | United States | United States |
| Employees | N/A | 2592 |
| Industry | Biotechnology: Pharmaceutical Preparations | Cable & Other Pay Television Services |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 641.2M |
| IPO Year | 2020 | 2015 |
| Metric | HRMY | CABO |
|---|---|---|
| Price | $27.62 | $113.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 4 |
| Target Price | $46.70 | ★ $125.67 |
| AVG Volume (30 Days) | ★ 1.1M | 129.3K |
| Earning Date | 05-18-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.97 | N/A |
| EPS | ★ 2.71 | N/A |
| Revenue | $868,453,000.00 | ★ $1,501,423,000.00 |
| Revenue This Year | $19.87 | N/A |
| Revenue Next Year | $12.49 | $1.94 |
| P/E Ratio | $10.23 | ★ N/A |
| Revenue Growth | ★ 21.51 | N/A |
| 52 Week Low | $25.52 | $70.37 |
| 52 Week High | $40.87 | $277.97 |
| Indicator | HRMY | CABO |
|---|---|---|
| Relative Strength Index (RSI) | 29.93 | 57.01 |
| Support Level | $25.71 | $96.67 |
| Resistance Level | $30.96 | $116.53 |
| Average True Range (ATR) | 1.12 | 8.29 |
| MACD | 0.08 | 0.89 |
| Stochastic Oscillator | 47.95 | 89.02 |
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Cable One Inc is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. The company derives majority of its revenue from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols.